Added to YB: 2026-06-10
Pitch date: 2026-06-07
FLRY3.SA [bullish]
Fleury S.A.
+0.55%
current return
Author Info
Researching Global Stocks searches the globe for long-term investment opportunities. Sign up for the newsletter.
Company Info
Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil.
Market Cap
BRL 7.9B
Pitch Price
BRL 14.53
Price Target
N/A
Dividend
8.28%
EV/EBITDA
5.13
P/E
12.54
EV/Sales
1.32
Sector
Health Care Providers and Services
Category
dividend
Fleury S.A. - $FLRY3.SA
FLRY3.SA: Brazilian diagnostics leader, 13% mkt share, 598 units, 33 brands. B2C 69%, B2B 22% (Lab-to-Lab CAGR 11.7%), Novos Elos 9% (82% growth). Rev CAGR 19.2% w/ M&A, 16-17% ROIC, 1.0x net debt/EBITDA, ~100% cash conversion. 12.6x P/E, 8.2% yield. Aging demographics tailwind, but insurer-dependent, macro-sensitive.
Read full article (11 min)